Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
Haematologica. 2023 Nov 1;108(11):3148-3151.
doi: 10.3324/haematol.2023.282733.
1 Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. [email protected].
2 SWOG Statistical Center, Fred Hutch Cancer Center, Seattle, WA, USA.
3 Departments of Oncology and Hematology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA.
4 Departments of Oncology and Hematology, University of Washington, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA.
5 Duke Cancer Institute, Durham, NC, USA.
6 Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
7 Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, WA, USA.
8 Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, WA, USA; Departments of Oncology and Hematology, University of Washington, Seattle, WA, USA.
9 Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.
10 Genomics and Bioinformatics Shared Resource, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
11 Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA.